<p>Fiduciary Management Inc. WI 在最近向美国证券交易委员会提交的 13F 表格中表示，在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 免费报告) 的持股比例降低了 9.1%。该公司在季度内出售了 495,419 股后，持有 4,961,969 股该公司的股票。Fiduciary Management Inc. WI 在最近一个季度末持有 Fresenius Medical Care AG &amp; Co. KGaA 约 0.86% 的股份，价值 118,194,000 美元。</p>
<ul>
<li>医院股票 - 最佳医院股票推荐</li>
</ul>
<p>其他几家机构投资者最近也对 FMS 的持仓进行了调整。美国银行公司 DE 在第二季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 279.7%。美国银行公司 DE 目前持有 337,316 股该公司的股票，价值 9,637,000 美元，此前在此期间又购买了 248,477 股。ABC Arbitrage SA 在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1,136.0%。ABC Arbitrage SA 目前持有 249,800 股该公司的股票，价值 5,950,000 美元，此前在此期间又购买了 229,589 股。Pzena Investment Management LLC 在第三季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1.0%。Pzena Investment Management LLC 目前持有 14,816,852 股该公司的股票，价值 390,128,000 美元，此前在此期间又购买了 153,870 股。Qube Research &amp; Technologies Ltd 在第二季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 175.3%。Qube Research &amp; Technologies Ltd 目前持有 199,563 股该公司的股票，价值 5,702,000 美元，此前在此期间又购买了 127,073 股。最后，Moran Wealth Management LLC 在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 67.4%。Moran Wealth Management LLC 目前持有 264,462 股该公司的股票，价值 6,299,000 美元，此前在此期间又购买了 106,438 股。机构投资者目前持有该公司 8.37% 的股份。</p>
<h2>分析师设定新目标价</h2>
<p>几位研究分析师最近对 FMS 股票发表了看法。Zacks Research 在 5 月 27 日的报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的股票评级从 &#34;持有&#34; 下调至 &#34;强烈卖出&#34;。Wall Street Zen 在 5 月 9 日的报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的股票评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。Weiss Ratings 在 5 月 7 日的研究报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的评级从 &#34;持有 (c+)&#34; 下调至 &#34;持有 (c)&#34;。花旗集团在 4 月 24 日的研究报告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;中性&#34; 评级。最后，摩根士丹利在 5 月 6 日的研究报告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;减持&#34; 评级。四位分析师对该股票给予了持有评级，五位分析师对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 &#34;强烈卖出&#34;，共识目标价为 28.00 美元。</p>
<ul>
<li>最佳医疗保健股票 - 现在值得购买的医疗保健股票</li>
</ul>
<p><strong>获取我们关于 Fresenius Medical Care AG &amp; Co. KGaA 的最新股票报告</strong></p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 股票上涨 0.4%</h2>
<p>FMS 周五开盘价为 22.03 美元。该股票的市值为 119 亿美元，市盈率为 11.59，市盈率/增长比率为 3.97，贝塔值为 0.80。该公司的速动比率为 0.86，流动比率为 1.20，债务与股本比率为 0.40。Fresenius Medical Care AG &amp; Co. KGaA 的 52 周低点为 20.02 美元，52 周高点为 29.07 美元。该公司的 50 日简单移动平均线为 22.23 美元，200 日简单移动平均线为 22.87 美元。</p>
<p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 获取免费报告) 最近于 3 月 31 日发布了其财报。该公司报告季度每股收益为 1.05 美元。该业务的季度收入为 53.4 亿美元。Fresenius Medical Care AG &amp; Co. KGaA 的股本回报率为 8.90%，净利润率为 4.88%。作为一个整体，研究分析师预计 Fresenius Medical Care AG &amp; Co. KGaA 在当前财政年度将发布 2.24 美元的每股收益。</p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 增加股息</h2>
<p>该公司最近还宣布了一项年度股息，将于 6 月 8 日支付。5 月 22 日的登记投资者将获得 0.8716 美元的股息。这比 Fresenius Medical Care AG &amp; Co. KGaA 之前的年度股息 0.79 美元有所增加。这代表了 402.0% 的收益率。该股息的除息日期为 5 月 22 日。Fresenius Medical Care AG &amp; Co. KGaA 目前的派息比率为 32.11%。</p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 公司简介</h2>
<p>(免费报告)</p>
<p>Fresenius Medical Care AG &amp; Co KGaA 是全球最大的肾脏疾病产品和服务的综合供应商。该公司的主要业务活动包括运营透析诊所以及制造和分销透析设备、透析机、透析器、耗材和相关疗法。通过其全球诊所网络，Fresenius Medical Care 提供全面的肾脏护理，包括血液透析和腹膜透析治疗、患者教育和支持服务。</p>
<p>在其产品部门，该公司设计和生产透析机、水处理系统以及高通量透析器和血管通路等一次性耗材。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara 刚刚回答了 AI 问题——华尔街准备好倾听了吗？</li>
<li>IREN 的 800MW 投资开启了 AI 电力开关</li>
<li>CrowdStrike 财报超预期引发抛售——是否值得买入？</li>
<li>特斯拉的电动车反弹让 Rivian 和 Lucid 面临更严峻的投资者考验</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 吗？</h2>
<p>在考虑 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Fresenius Medical Care AG &amp; Co. KGaA 并不在名单上。</p>
<p>虽然 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析师中被评为强烈卖出，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Fiduciary Management Inc. WI 在第四季度减少了对 Fresenius Medical Care AG & Co. KGaA (FMS) 的持股，减持幅度为 9.1%，出售了 495,419 股。其他机构如美国银行和 ABC Arbitrage 则增加了持股。分析师最近下调了 FMS 的评级，Zacks 将其评级降至 “强烈卖出”，其他机构也进行了评级调整，导致共识评级为 “强烈卖出”，目标价为 28 美元。该股票目前交易价格约为 22 美元，最近的财报显示每股收益为 1.05 美元</p>

<p>Fiduciary Management Inc. WI lowered its position in Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,961,969 shares of the company's stock after selling 495,419 shares during the quarter. Fiduciary Management Inc. WI owned about 0.86% of Fresenius Medical Care AG &amp; Co. KGaA worth $118,194,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Fiduciary Management Inc. WI 在最近向美国证券交易委员会提交的 13F 表格中表示，在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 免费报告) 的持股比例降低了 9.1%。该公司在季度内出售了 495,419 股后，持有 4,961,969 股该公司的股票。Fiduciary Management Inc. WI 在最近一个季度末持有 Fresenius Medical Care AG &amp; Co. KGaA 约 0.86% 的股份，价值 118,194,000 美元。</p>
</div><ul>
<li>Hospital Stocks - Best Hospital Stocks to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>医院股票 - 最佳医院股票推荐</li>
</ul>
</div><p>Several other institutional investors have also recently made changes to their positions in FMS. Bank of America Corp DE increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 279.7% in the second quarter. Bank of America Corp DE now owns 337,316 shares of the company's stock worth $9,637,000 after purchasing an additional 248,477 shares during the period. ABC Arbitrage SA increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 1,136.0% in the fourth quarter. ABC Arbitrage SA now owns 249,800 shares of the company's stock worth $5,950,000 after purchasing an additional 229,589 shares during the period. Pzena Investment Management LLC increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 1.0% in the third quarter. Pzena Investment Management LLC now owns 14,816,852 shares of the company's stock worth $390,128,000 after purchasing an additional 153,870 shares during the period. Qube Research &amp; Technologies Ltd increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 175.3% in the second quarter. Qube Research &amp; Technologies Ltd now owns 199,563 shares of the company's stock worth $5,702,000 after purchasing an additional 127,073 shares during the period. Finally, Moran Wealth Management LLC increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 67.4% in the fourth quarter. Moran Wealth Management LLC now owns 264,462 shares of the company's stock worth $6,299,000 after purchasing an additional 106,438 shares during the period. Institutional investors own 8.37% of the company's stock.</p>
<div class="lb-trans"><p>其他几家机构投资者最近也对 FMS 的持仓进行了调整。美国银行公司 DE 在第二季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 279.7%。美国银行公司 DE 目前持有 337,316 股该公司的股票，价值 9,637,000 美元，此前在此期间又购买了 248,477 股。ABC Arbitrage SA 在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1,136.0%。ABC Arbitrage SA 目前持有 249,800 股该公司的股票，价值 5,950,000 美元，此前在此期间又购买了 229,589 股。Pzena Investment Management LLC 在第三季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1.0%。Pzena Investment Management LLC 目前持有 14,816,852 股该公司的股票，价值 390,128,000 美元，此前在此期间又购买了 153,870 股。Qube Research &amp; Technologies Ltd 在第二季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 175.3%。Qube Research &amp; Technologies Ltd 目前持有 199,563 股该公司的股票，价值 5,702,000 美元，此前在此期间又购买了 127,073 股。最后，Moran Wealth Management LLC 在第四季度将其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 67.4%。Moran Wealth Management LLC 目前持有 264,462 股该公司的股票，价值 6,299,000 美元，此前在此期间又购买了 106,438 股。机构投资者目前持有该公司 8.37% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several research analysts have recently weighed in on FMS shares. Zacks Research cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a report on Wednesday, May 27th. Wall Street Zen cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, May 9th. Weiss Ratings cut Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold (c+)&#34; rating to a &#34;hold (c)&#34; rating in a research note on Thursday, May 7th. Citigroup reissued a &#34;neutral&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Friday, April 24th. Finally, Morgan Stanley reissued an &#34;underweight&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Wednesday, May 6th. Four analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of &#34;Strong Sell&#34; and a consensus price target of $28.00.</p>
<div class="lb-trans"><p>几位研究分析师最近对 FMS 股票发表了看法。Zacks Research 在 5 月 27 日的报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的股票评级从 &#34;持有&#34; 下调至 &#34;强烈卖出&#34;。Wall Street Zen 在 5 月 9 日的报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的股票评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。Weiss Ratings 在 5 月 7 日的研究报告中将 Fresenius Medical Care AG &amp; Co. KGaA 的评级从 &#34;持有 (c+)&#34; 下调至 &#34;持有 (c)&#34;。花旗集团在 4 月 24 日的研究报告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;中性&#34; 评级。最后，摩根士丹利在 5 月 6 日的研究报告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;减持&#34; 评级。四位分析师对该股票给予了持有评级，五位分析师对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 &#34;强烈卖出&#34;，共识目标价为 28.00 美元。</p>
</div><ul>
<li>Best Healthcare Stocks - Healthcare Stocks to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>最佳医疗保健股票 - 现在值得购买的医疗保健股票</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Fresenius Medical Care AG &amp; Co. KGaA</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Fresenius Medical Care AG &amp; Co. KGaA 的最新股票报告</strong></p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Stock Up 0.4%</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 股票上涨 0.4%</h2>
</div><p>FMS opened at $22.03 on Friday. The stock has a market cap of $11.90 billion, a PE ratio of 11.59, a P/E/G ratio of 3.97 and a beta of 0.80. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG &amp; Co. KGaA has a 52 week low of $20.02 and a 52 week high of $29.07. The business's fifty day simple moving average is $22.23 and its 200 day simple moving average is $22.87.</p>
<div class="lb-trans"><p>FMS 周五开盘价为 22.03 美元。该股票的市值为 119 亿美元，市盈率为 11.59，市盈率/增长比率为 3.97，贝塔值为 0.80。该公司的速动比率为 0.86，流动比率为 1.20，债务与股本比率为 0.40。Fresenius Medical Care AG &amp; Co. KGaA 的 52 周低点为 20.02 美元，52 周高点为 29.07 美元。该公司的 50 日简单移动平均线为 22.23 美元，200 日简单移动平均线为 22.87 美元。</p>
</div><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) last released its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. The business had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG &amp; Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%. As a group, research analysts expect that Fresenius Medical Care AG &amp; Co. KGaA will post 2.24 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 获取免费报告) 最近于 3 月 31 日发布了其财报。该公司报告季度每股收益为 1.05 美元。该业务的季度收入为 53.4 亿美元。Fresenius Medical Care AG &amp; Co. KGaA 的股本回报率为 8.90%，净利润率为 4.88%。作为一个整体，研究分析师预计 Fresenius Medical Care AG &amp; Co. KGaA 在当前财政年度将发布 2.24 美元的每股收益。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Increases Dividend</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 增加股息</h2>
</div><p>The company also recently announced an annual dividend, which will be paid on Monday, June 8th. Investors of record on Friday, May 22nd will be paid a $0.8716 dividend. This is a boost from Fresenius Medical Care AG &amp; Co. KGaA's previous annual dividend of $0.79. This represents a yield of 402.0%. The ex-dividend date of this dividend is Friday, May 22nd. Fresenius Medical Care AG &amp; Co. KGaA's payout ratio is currently 32.11%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项年度股息，将于 6 月 8 日支付。5 月 22 日的登记投资者将获得 0.8716 美元的股息。这比 Fresenius Medical Care AG &amp; Co. KGaA 之前的年度股息 0.79 美元有所增加。这代表了 402.0% 的收益率。该股息的除息日期为 5 月 22 日。Fresenius Medical Care AG &amp; Co. KGaA 目前的派息比率为 32.11%。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Fresenius Medical Care AG &amp; Co KGaA is the world's largest integrated provider of products and services for individuals with renal diseases. The company's primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG &amp; Co KGaA 是全球最大的肾脏疾病产品和服务的综合供应商。该公司的主要业务活动包括运营透析诊所以及制造和分销透析设备、透析机、透析器、耗材和相关疗法。通过其全球诊所网络，Fresenius Medical Care 提供全面的肾脏护理，包括血液透析和腹膜透析治疗、患者教育和支持服务。</p>
</div><p>In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.</p>
<div class="lb-trans"><p>在其产品部门，该公司设计和生产透析机、水处理系统以及高通量透析器和血管通路等一次性耗材。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?</li>
<li>IREN's 800MW Bet Flips the AI Power Switch</li>
<li>CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?</li>
<li>Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara 刚刚回答了 AI 问题——华尔街准备好倾听了吗？</li>
<li>IREN 的 800MW 投资开启了 AI 电力开关</li>
<li>CrowdStrike 财报超预期引发抛售——是否值得买入？</li>
<li>特斯拉的电动车反弹让 Rivian 和 Lucid 面临更严峻的投资者考验</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=FMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care AG &amp; Co. KGaA Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 吗？</h2>
</div><p>Before you consider Fresenius Medical Care AG &amp; Co. KGaA, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care AG &amp; Co. KGaA wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Fresenius Medical Care AG &amp; Co. KGaA 并不在名单上。</p>
</div><p>While Fresenius Medical Care AG &amp; Co. KGaA currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析师中被评为强烈卖出，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Fiduciary Management Inc. WI Sells 495,419 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

Market Beat

Fresenius Medical Care

美国银行

花旗

摩根士丹利

Fresenius Medical Care AG & Co. KGaA

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

CITIGROUP INC 6.250 NON CUM SER II PFD WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Fiduciary Management Inc. WI 出售了 495,419 股 Fresenius Medical Care AG & Co. KGaA 的股票，股票代码为 $FMS